The pharmaceutical CMO market thrives on increased outsourcing due to strategic realignment and advanced therapy approvals. Expanding in Asia-Pacific and integrated service offerings further drive ...
NMPA's new CMO rules highlight regulatory compliance in pharma licensing—from diligence to structure and key terms. By丨 ...
The Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) market has been experiencing significant growth in recent years, driven by the increasing ...
Contract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective capacity and production agility was on full display during the COVID-19 ...
The Nanoparticle Contract Manufacturing market offers opportunities in pharmaceuticals, biotech, and advanced materials, driven by demand for complex nanoparticle formulations. CMOs enhance ...
TOKYO, June 5, 2025 /PRNewswire/ -- bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, today announced a new partnership ...
SEOUL, Nov. 4 (Yonhap) -- Samsung Biologics Co., the biotech arm of Samsung Group, said Tuesday it has secured contract manufacturing deals worth more than 5.5 trillion won (US$3.82 billion) in the ...
Lotte Biologics has signed a contract manufacturing organization agreement with Rakuten Medical to support the latter’s ...
Celltrion said on the 2nd that it has completed the acquisition of Eli Lilly and Company's biopharmaceutical manufacturing facility in the United States and will begin full-scale contract ...
Symbiosis Pharmaceutical Services, a CMO, purchased new premises in Stirling, Scotland. The additional space will increase manufacturing capacity, strengthen the current Symbiosis commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results